Dr. Alyson Nicole Fox, MD

Dr. Fox practices at Columbia University Irving Medical Center in New York, New York.

Dr. Fox's NPI, 1114136967, was assigned on May 21, 2007. Dr. Fox graduated from Icahn School Of Medicine At Mount Sinai in 2004. Dr. Fox holds New York license 239991.

Dr. Fox's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Fox's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Fox is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Fox to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fox practices. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Fox's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dr. Fox is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Fox's licenses on file in 5 states: New York, California, New Jersey, Connecticut and Pennsylvania.

Dmand AI lists cirrhosis of the liver and liver disease among the conditions Dr. Fox treats.

CMS data shows 241 Medicare services from Dr. Fox across 7 procedure codes in 2024, for 107 Medicare patients. Medicare paid $22,520 for them.

CMS counts 107 Medicare patients who saw Dr. Fox in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fox's median patient age at 55, with 51% women.

In 2024, Dr. Fox wrote 69 Medicare Part D claims for 24 patients. 70% of them were for generic drugs. CMS names the drug for 24 of them, across 2 drugs with 11 or more claims each, at $512 in total drug cost. In 2021, CMS named 40 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Fox for performance year 2024, reported through an alternative payment model (APM). Dr. Fox accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fox as offering telehealth.

Dmand AI links 35 papers to Dr. Fox, published from 2011 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Liver Transplantation, Living Donors and Axons. Dr. Fox has published most often in Am J Transplant. Dr. Fox's most frequent co-authors are Jean Crawford Emond, MD, Elizabeth Clarice Verna, MD and Robert Stephen Brown, MD.

Dmand AI links Dr. Fox to 1 clinical trial. Conditions studied include Hepatopulmonary Syndrome and Liver Diseases.

CMS Open Payments shows 137 general payments to Dr. Fox from 32 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 43% of the total. Novartis Pharmaceuticals Corporation paid the most, $4,587.

Dmand AI lists 1 award for Dr. Fox, most recently CMS Stage 1 EHR in 2013.

Dr. Fox graduated from Icahn School Of Medicine At Mount Sinai in 2004.

Dr. Fox is in network with 15 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.